DE602005026394D1 - Therapeutische kombinationen - Google Patents
Therapeutische kombinationenInfo
- Publication number
- DE602005026394D1 DE602005026394D1 DE602005026394T DE602005026394T DE602005026394D1 DE 602005026394 D1 DE602005026394 D1 DE 602005026394D1 DE 602005026394 T DE602005026394 T DE 602005026394T DE 602005026394 T DE602005026394 T DE 602005026394T DE 602005026394 D1 DE602005026394 D1 DE 602005026394D1
- Authority
- DE
- Germany
- Prior art keywords
- therapeutic combinations
- betaine
- administration
- cholesterol
- kidneys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE2004/0364A BE1016128A6 (fr) | 2004-07-22 | 2004-07-22 | Combinaisons therapeutiques |
PCT/BE2005/000112 WO2006007671A2 (fr) | 2004-07-22 | 2005-07-13 | Combinaisons therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005026394D1 true DE602005026394D1 (de) | 2011-03-31 |
Family
ID=35462104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005026394T Active DE602005026394D1 (de) | 2004-07-22 | 2005-07-13 | Therapeutische kombinationen |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070134324A1 (de) |
EP (1) | EP1773450B1 (de) |
AT (1) | ATE498427T1 (de) |
BE (1) | BE1016128A6 (de) |
DE (1) | DE602005026394D1 (de) |
DK (1) | DK1773450T3 (de) |
ES (1) | ES2361284T3 (de) |
PL (1) | PL1773450T3 (de) |
PT (1) | PT1773450E (de) |
WO (1) | WO2006007671A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1015608A6 (fr) | 2003-07-15 | 2005-06-07 | Messadek Jallal | Traitement des arterites. |
WO2004091601A1 (fr) * | 2003-04-17 | 2004-10-28 | Jallal Messadek | Formulations orales flottantes pour la liberation controlee de la betaine |
US7785740B2 (en) * | 2004-04-09 | 2010-08-31 | Air Products And Chemicals, Inc. | Overcharge protection for electrochemical cells |
WO2006050581A2 (en) | 2004-11-10 | 2006-05-18 | Jallal Messadek | Betaine as agent against arthropod - or mosquito -borne diseases |
WO2006086856A1 (en) | 2005-02-15 | 2006-08-24 | Messadek, Jallal | Combination therapeutic compositions and method of use |
CN101180073A (zh) | 2005-04-27 | 2008-05-14 | 贾拉尔·梅萨德克 | 胰岛素组合 |
US20090326013A1 (en) * | 2007-03-01 | 2009-12-31 | Curt Hendrix | Isomers of inositol niacinate and uses thereof |
WO2009065193A1 (en) * | 2007-11-21 | 2009-05-28 | Jallal Messadek | Treatment of aspirin resistance with betaine and/or betaine enriched molasses |
KR101783945B1 (ko) | 2009-05-12 | 2017-10-10 | 비피에스아이 홀딩스, 엘엘씨. | 향상된 수분차단 속방출형 필름의 코팅 시스템 및 이에 의하여 코팅된 기재 |
CA2760037A1 (en) * | 2009-05-12 | 2010-11-18 | Bpsi Holdings, Llc | Film coatings containing fine particle size detackifiers and substrates coated therewith |
KR101296328B1 (ko) * | 2009-09-21 | 2013-08-14 | 주식회사 삼양바이오팜 | 피브레이트계 약물을 포함하는 고체분산체 및 이의 제조방법 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US580098A (en) * | 1897-04-06 | Governor for water-motors | ||
US3577534A (en) * | 1968-06-20 | 1971-05-04 | Canada Packers Ltd | Stable orally active heparinoid complexes |
GB1509979A (en) * | 1975-11-28 | 1978-05-10 | Fisons Ltd | Pharmaceutical compositions containing aspirin or indomethacin |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4605548A (en) * | 1983-05-31 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Drug administration material |
GB8325627D0 (en) * | 1983-09-24 | 1983-10-26 | Scras | Therapeutic compositions |
DK162986A (da) * | 1985-04-12 | 1986-10-13 | Forest Laboratories | Terapeutisk middel i enhedsdosisform |
AU607172B2 (en) * | 1986-12-22 | 1991-02-28 | Cygnus, Inc. | Diffusion matrix for transdermal drug administration |
US4902718A (en) * | 1988-04-08 | 1990-02-20 | Bayless Robert K | Calcium homeostasis compositions and methods for controlling calcium metabolism |
US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
EP0441119A3 (en) * | 1990-01-09 | 1992-10-14 | Richard D. Levere | The use of l-arginine in the treatment of hypertension and other vascular disorders |
US5405614A (en) * | 1992-04-08 | 1995-04-11 | International Medical Associates, Inc. | Electronic transdermal drug delivery system |
US5342621A (en) * | 1992-09-15 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Antithrombogenic surface |
US5876780A (en) * | 1993-04-29 | 1999-03-02 | Cultor, Ltd. | Compositions for treating coccidiosis |
US5716941A (en) * | 1993-07-07 | 1998-02-10 | Biogenesys | Use of methyl donor compounds to treat neurological dysfunction associated with immune defects |
US5814599A (en) * | 1995-08-04 | 1998-09-29 | Massachusetts Insitiute Of Technology | Transdermal delivery of encapsulated drugs |
US6355166B1 (en) * | 1994-08-25 | 2002-03-12 | The University Of Iowa Research Foundation | Magnetically enhanced composite materials and methods for making and using the same |
US6056958A (en) * | 1994-12-09 | 2000-05-02 | Dupont Pharmaceuticals | Method of treatment of arterial and venous thromboembolic disorders |
US5961999A (en) * | 1995-06-08 | 1999-10-05 | Wella Aktiengesellschaft | Method of skin care using a skin care preparation containing a betaine ester and an α-hydroxy acid |
US6162926A (en) * | 1995-07-31 | 2000-12-19 | Sphere Biosystems, Inc. | Multi-substituted fullerenes and methods for their preparation and characterization |
US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
WO1997027829A1 (en) * | 1996-01-31 | 1997-08-07 | The Trustees Of The University Of Pennsylvania | Remote control drug delivery device |
US5688499A (en) * | 1996-03-13 | 1997-11-18 | Queen's University At Kingston | Antagonism of endothelin actions |
US5880098A (en) * | 1996-04-12 | 1999-03-09 | Pharmacia & Upjohn Aktiebolag | Therapeutic treatment |
IL119029A0 (en) * | 1996-08-07 | 1996-11-14 | Yeda Res & Dev | Long-acting drugs and pharamaceutical compositions comprising them |
US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
US6287765B1 (en) * | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
BE1012495A3 (fr) * | 1999-03-02 | 2000-11-07 | Messadek Jallal | La glycine-betaine pour son usage antithrombotique. |
US7608640B2 (en) * | 1999-03-02 | 2009-10-27 | Jallal Messadek | Glycine betaine and its use |
WO2002062322A2 (en) * | 2001-02-05 | 2002-08-15 | Jallal Messadek | Glycine betaine and its use as anti-hemorrhagic agent |
DE19910682B4 (de) * | 1999-03-10 | 2004-09-02 | Dierkes, Jutta, Dr. | Verwendung eines Kombinationspräparates zur Therapie einer Fibrat-induzierten Hyperhomocysteinämie |
CN1313080C (zh) * | 2000-04-20 | 2007-05-02 | 斯凯伊药品加拿大公司 | 改进的水不溶性药物粒子的制备方法 |
US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
US6881420B2 (en) * | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
FR2811227A1 (fr) * | 2000-07-07 | 2002-01-11 | Philippe Maincent | Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs |
US6624180B2 (en) * | 2000-11-20 | 2003-09-23 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
FI114538B (fi) * | 2001-01-12 | 2004-11-15 | Finnfeeds Finland Ltd | Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen |
GB0108930D0 (en) * | 2001-04-10 | 2001-05-30 | Boots Co Plc | Therapeutic agents |
US20040072750A1 (en) * | 2001-05-03 | 2004-04-15 | David Phillips | Compounds and methods for the modulation of CD154 |
US6531171B2 (en) * | 2001-07-03 | 2003-03-11 | Nutricia Usa, Inc. | Food products containing betaine |
US20060160896A1 (en) * | 2002-02-04 | 2006-07-20 | Jallal Messadek | Therapeutic treatment |
US20030187074A1 (en) * | 2002-03-04 | 2003-10-02 | Javed Hussain | Oral compositions for treatment of diabetes |
EP1518120A4 (de) * | 2002-03-11 | 2008-08-13 | Momenta Pharmaceuticals Inc | Analyse sulfatierter polysaccharide |
US7985422B2 (en) * | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
US20040067986A1 (en) * | 2002-10-04 | 2004-04-08 | Nathan Sassover | Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
US20060233877A1 (en) * | 2002-11-25 | 2006-10-19 | Jallal Messadek | Betaine compositions |
WO2004091601A1 (fr) * | 2003-04-17 | 2004-10-28 | Jallal Messadek | Formulations orales flottantes pour la liberation controlee de la betaine |
US7097968B2 (en) * | 2003-07-10 | 2006-08-29 | General Atomics | Methods and compositions for assaying homocysteine |
US20060128657A1 (en) * | 2003-08-04 | 2006-06-15 | Jallal Messadek | Selected betaines and their uses |
EP1663174A1 (de) * | 2003-08-05 | 2006-06-07 | Galephar M/F | Einzelne pharmazeutische zusammensetzung mit einem gemisch aus einem fibrat und einem homocysteine-reduktionsmittel |
US7115947B2 (en) * | 2004-03-18 | 2006-10-03 | International Business Machines Corporation | Multiple dielectric finfet structure and method |
-
2004
- 2004-07-22 BE BE2004/0364A patent/BE1016128A6/fr not_active IP Right Cessation
-
2005
- 2005-07-13 PT PT05763958T patent/PT1773450E/pt unknown
- 2005-07-13 DK DK05763958.5T patent/DK1773450T3/da active
- 2005-07-13 EP EP05763958A patent/EP1773450B1/de not_active Not-in-force
- 2005-07-13 DE DE602005026394T patent/DE602005026394D1/de active Active
- 2005-07-13 AT AT05763958T patent/ATE498427T1/de active
- 2005-07-13 WO PCT/BE2005/000112 patent/WO2006007671A2/fr active Application Filing
- 2005-07-13 ES ES05763958T patent/ES2361284T3/es active Active
- 2005-07-13 PL PL05763958T patent/PL1773450T3/pl unknown
-
2007
- 2007-01-22 US US11/625,448 patent/US20070134324A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1773450E (pt) | 2011-05-18 |
WO2006007671A2 (fr) | 2006-01-26 |
ATE498427T1 (de) | 2011-03-15 |
DK1773450T3 (da) | 2011-06-14 |
BE1016128A6 (fr) | 2006-03-07 |
PL1773450T3 (pl) | 2011-07-29 |
US20070134324A1 (en) | 2007-06-14 |
EP1773450A2 (de) | 2007-04-18 |
ES2361284T3 (es) | 2011-06-15 |
WO2006007671A3 (fr) | 2006-02-23 |
EP1773450B1 (de) | 2011-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1773450T3 (da) | Terapeutiske kombinationer | |
MX2007003907A (es) | Agentes terapeuticos con toxicidad reducida. | |
WO2006044362A3 (en) | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | |
WO2005016286A8 (en) | Pyrazine modulators of cannabinoid receptors | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
BRPI0413028A (pt) | composto, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
MX2007007885A (es) | Composiciones farmaceuticas oralmente desintegrables con agentes de indicacion sensorial. | |
EP2279732A3 (de) | Verbindungen und Zusammensetzungen zur Wirkstofffreisetzung | |
MX2007003078A (es) | Compuestos de imidazoquinolina. | |
DK1965797T3 (da) | Nedsættelse af svimmelhed, en bivirkning forbundet med pirfenidonterapi | |
UA103614C2 (uk) | Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
MX2009013779A (es) | Uso de agonistas de tlr y/o interferonas tipo 1 para aliviar la toxicidad de los regimenes terapeuticos de agonistas de tnf-r. | |
EA200870091A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
MX2007007504A (es) | Composiciones terapeuticas para la administracion intranasal de ketorolaco. | |
WO2005074536A3 (en) | Compositions and methods using proton pump inhibitors | |
RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
TW200603787A (en) | Topical preparations containing ambroxol | |
SE0401342D0 (sv) | Therapeutic compounds | |
RS54265B1 (en) | ADHESIVE CAPSULITIS TREATMENT PROCEDURES | |
WO2008042480A3 (en) | Epoxide inhibitors of cysteine proteases | |
MX2009005798A (es) | Recuperacion de apoplejia. | |
LU92202I9 (de) | ||
TW200730190A (en) | New combination to treat liver fibrosis |